Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.860
+0.100 (2.66%)
At close: Mar 6, 2026, 4:00 PM EST
3.870
+0.010 (0.26%)
After-hours: Mar 6, 2026, 5:15 PM EST
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $59.73 million as of March 6, 2026. Its market cap has increased by 73.63% in one year.
Market Cap
59.73M
Enterprise Value
41.06M
1-Year Change
73.63%
Ranking
Category
Stock Price
$3.86
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $59.73M, a decrease of -99.12%. That is a compound annual growth rate of -34.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 59.70M | 22.09% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 63.33M |
| InflaRx | 62.02M |
| NeurAxis | 61.89M |
| Spruce Biosciences | 61.59M |
| TScan Therapeutics | 61.29M |
| Metagenomi Therapeutics | 60.07M |
| Entera Bio | 59.61M |
| NRx Pharmaceuticals | 59.60M |